Trials / Active Not Recruiting
Active Not RecruitingNCT07374068
Prognostic Model of Elderly Hodgkin Lymphoma in China
Clinical Characteristics and Prognostic Model Analysis of Elderly Patients With Hodgkin Lymphoma in China
- Status
- Active Not Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 400 (estimated)
- Sponsor
- Tianjin Medical University Cancer Institute and Hospital · Academic / Other
- Sex
- All
- Age
- 60 Years
- Healthy volunteers
- Not accepted
Summary
This multicenter observational cohort study is based on a patient registry designed to systematically collect uniform real-world clinical data from elderly patients with Hodgkin lymphoma (HL) in China. The registry captures demographic characteristics, disease features, laboratory parameters, treatment patterns, and longitudinal survival outcomes to support predefined scientific objectives. The primary analysis uses retrospectively collected registry data, with prospectively accrued data incorporated for external validation of a prognostic prediction model. This registry-based study aims to improve risk stratification and inform individualized clinical decision-making for elderly patients with HL in routine clinical practice.
Conditions
Timeline
- Start date
- 2025-12-09
- Primary completion
- 2028-12-01
- Completion
- 2028-12-01
- First posted
- 2026-01-28
- Last updated
- 2026-01-28
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT07374068. Inclusion in this directory is not an endorsement.